Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Forest's propranolol sustained release

Executive Summary

Firm receives first ANDA approval on April 11 to market generic of Ayerst's Inderal LA. Forest obtained approval for all four strengths of Inderal LA: 60, 80, 120 and 160 mg. The company plans to begin shipping the product in early may. Forest has not released prices for the generic yet, but estimates that it will be roughly 60% of Inderal LA's cost. Inderal LA sales are in the roughly $100 mil. range, according to Forest.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS015460

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel